Webinar: An Update on Lecanemab for Early Stage Alzheimer’s Disease
September 26, 2024, 12pm to 1pm
Patients, families, and the wider community are invited to talk about the current amyloid-clearing infusion medications Leqembi (lecanemab) and Kisunla (donanemab) for the treatment of Alzheimer's. Come learn from our panel of experts which include, Dr. Thomas Grabowski, Dr. Michael Rosenbloom and clinical trials coordinator Darla Chapman, ARNP.
• Who is eligible for these treatments?
• What are the risks and benefits?
• What is the process if you're interested in these medications?
• What is the impact of these medications as well as similar ones in the pipeline for the clinic community and research?
• How has it been going for those patients who have been given the Leqembi infusion?
Location: Zoom
Upcoming Events in Community Talks and Outreach
No upcoming events are currently on the schedule. Please check again soon!